Videos

October 15, 2018  |  NIDA's Dr. Marco Venniro discusses his new study which finds that social interactions can have a profound effect on behaviors related to addiction, and on the brain’s response to drug-associated

September 21, 2018  |  NIDA's Clinical Trail's Initiative (CTN) video provides an overview of Buprenorphine, a semi-synthetic opioid, used in the treatment of adults with opioid use disorder.

September 21, 2018  |  NIDA's Clinical Trail's Initiative (CTN) video provides an overview of Buprenorphine, a semi-synthetic opioid, used in the treatment of adults with opioid use disorder. The video highlights the opioid epidemic

September 18, 2018  |  Innovative strategies that entail increasing access to care, identifying those at high risk for overdose, safe prescribing, offering access to Naloxone, sharing data among agencies, and decreasing stigma.

September 14, 2018  |  Emergency physicians around the country have partnered with state entities to develop a spectrum of innovative strategies: increasing access to care, identifying those at high risk for overdose, safe prescribing

September 14, 2018  |  Emergency physicians around the country have partnered with state entities to develop a spectrum of innovative strategies: increasing access to care, identifying those at high risk for overdose, safe prescribing

September 14, 2018  |  A spectrum of innovative strategies that entail increasing access to care, identifying those at high risk for overdose, safe prescribing, offering access to Naloxone, sharing data among agencies, and decreasing

July 10, 2018  |  Dr. Wilson Compton discusses research that found that synthetic opioids, such as illicit fentanyl, have surpassed prescription opioids as the most common drug involved in overdose deaths in the U.S.

May 1, 2018  |  NIDA's Dr. Emily Einstein discusses overdose deaths and the tools used for research. Findings found that synthetic opioids, such as illicit fentanyl, have surpassed prescription opioids as the most common

December 14, 2017  |  NIDA Director, Dr. Nora Volkow, discusses the range and limitations of the Monitoring the Future (MTF) survey, which focuses on drug use and attitudes among America’s 8th, 10th, and 12th